ALTABRYTE Trademark

Trademark Overview

On Tuesday, February 1, 2022, a trademark application was filed for ALTABRYTE with the United States Patent and Trademark Office. The USPTO has given the ALTABRYTE trademark a serial number of 97248791. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Astellas Pharma Inc.. The ALTABRYTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for intraoperative ureter and lymph node visualization for use during surgical and medical procedures; diagnostic agents, preparations, and substances for medical purposes; contrast media for in vivo imaging; contrast media for use with imaging medical equipment
altabryte

General Information

Serial Number97248791
Word MarkALTABRYTE
Filing DateTuesday, February 1, 2022
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6986228
Registration DateTuesday, February 21, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for intraoperative ureter and lymph node visualization for use during surgical and medical procedures; diagnostic agents, preparations, and substances for medical purposes; contrast media for in vivo imaging; contrast media for use with imaging medical equipment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Friday, February 4, 2022NEW APPLICATION ENTERED
Monday, February 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, February 20, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, February 24, 2022ASSIGNED TO LIE
Friday, February 25, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, April 14, 2022ASSIGNED TO EXAMINER
Wednesday, April 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 20, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 5, 2022ASSIGNED TO LIE
Monday, August 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 1, 2022TEAS DELETE 1(B) BASIS RECEIVED
Thursday, December 1, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, January 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 10, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

Related Keywords

altabryte medical preparations contrast media imaging agents equipment substances purposes diagnostic